Carpio C, de la Cruz-Vicente F, Garcia-Sanz R, Zeberio I, et al. A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial. Br J Haematol 2025 Jul 25. doi: 10.1111/bjh.70028.
PMID: 40714959